Microsoft word - down syndrome - trisomy 21.doc

RSV – Recommended Literature
Down Syndrome/Trisomy 21

• Aboussouan LS, O’Donova PB, Moodie DS, Gragg LA, Stoller JK Hypoplastic trachea in Down’s Syndrome. Am Rev Resp Dis, 1993; 147: 72-5. • Bloemers BL, Bont L, de Weger RA, Otto SA, Borghans JA, and Tesselaar K. Decreased Thymic Output Accounts for Decreased Naïve T Cell numbers in Children with Down Syndrome. J Immunol 2011; 186:4500-4507 http://www.jimmunol.org/content/186/7/4500.full.pdf+html • Bloemers BL, van Bleek, GM, Kimpen, JL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr. 2010; 156 (5): 804-9. http://www.sciencedirect.com/science/article/pii/S0022347609012293 • Bloemers BL, Broers CJM, Bont L, Weijerman ME, Gemke R, van Furth A. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect 2010; 12 (11): 799-808. http://www.sciencedirect.com/science/article/pii/S1286457910001449 • Bloemers BL, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis–a prospective birth-cohort study. Pediatrics. 2007; 120: e1076–e1081. http://pediatrics.aappublications.org/content/120/4/e1076.full.html • Chaney RH, Eyman RK, Miller CR. The relationship of congenital heart disease and respiratory infection mortality in patients with Down syndrome. J Ment Def Res. 1985; 29: 23-27. • Clapp S, Perry BL, Farooki ZQ, et al. Down syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg. 1990; 100:115-121. • Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down’s syndrome. N Engl http://www.nejm.org/doi/full/10.1056/NEJM198211043071902 • Doull I. Respiratory disorders in Down’s syndrome: overview with diagnostic and treatment options. DSMIG (UK) 2001:1-19. • Garrison MM, Jeffries H, Christakis DA. Risk of death for children with Down syndrome. J Pediatr 2005; 147:748-52. http://www.sciencedirect.com/science/article/pii/S0022347605005871 • Greenwood RD, Nadas AS. The clinical course of cardiac disease in Down’s syndrome. Pediatrics 1976; 58: 893-7. http://pediatrics.aappublications.org/content/58/6/893.full.pdf+html • Gonzalez OR, Gomez IG, Recalde AL, Landing BH. Postnatal development of the cystic lung lesion of Down syndrome: suggestion that the cause is reduced formation of peripheral air spaces. Pediatr Pathol 1991; 11:623-33. • Gyves-Ray K, Kirchner S, Stein S, Heller R, Hernanz-Schulman M. Cystic lung disease in Down syndrome. Pediatr Radiol 1994; 24: 137-8. • Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, Svendsen AL, Nielsen BW. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 2009: 94 (10): 785-789. http://adc.bmj.com/content/94/10/785.full.pdf+html • Leonard S. Bower C, Petterson B, Leonard H. Survival of infants born with Down’s syndrome: 1980-96. Paediatr Pernia Epidemiol. 2000; 14 (2): 163- 171 http://onlinelibrary.wiley.com/doi/10.1046/j.1365-3016.2000.00252.x/pdf • Marcus, CL, Keens TG, Bautista DB, von Pechmann WS, Davidson Ward, SL. Obstructive sleep apnea in children with Down syndrome. Pediatr 1991; 88 (1): 132-139. http://pediatrics.aappublications.org/content/88/1/132.full.pdf+html • Piatti G, Allegra L, Ambrosetti U, Margherita De Santi, M. Nasal ciliary function and ultrastructure in Down syndrome. Laryngoscope 2001; 111 (7): 1227-1230. http://onlinelibrary.wiley.com/doi/10.1097/00005537-200107000-00016/pdf • Ram G, Chinen J. Infections and immunodeficiency in Down’s syndrome. Clin Exp Immunology 2011; 164 (1) :9-16 http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04335.x/pdf • Scholl T, Stein Z, Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down’s syndrome in the United States during 1976. Dev Med Child Neurolol 1982; 24: 817-29. • Shah PS, Hellmann J, Adatia I. Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn. J Perinatol Med. 2004: 32: 168-170. • Thase ME. Longevity and mortality in Down’s syndrome. J Ment Defic Res 1982; • Uong EC, McDonough JM, Tayag-Kier CE, et al. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med 2001; 163:731-736. http://ajrccm.atsjournals.org/content/163/3/731.full.pdf+html • Weijerman ME, Furth AM, Vonk Noordegraaf A, et al. Prevalence, neonatal characteristics and first-year mortality of Down syndrome: a national study. J Pediatr 2008; 152 (1) :15-19. http://www.sciencedirect.com/science/article/pii/S0022347607008955 • Yang Q, Rasmussen SA, Friedman JM. Morality associated with Down’s syndrome in the United States from 1983-1997: a population-based study. Lancet 2002; 359 (9311): 1019-25. http://www.sciencedirect.com/science/article/pii/S0140673602080923 • Zachariah P, Ruttenber M, Simoes EA. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study. J Pediatr 2012: 160 (5): 827-31.e1. http://www.sciencedirect.com/science/article/pii/S0022347611011279

Source: http://www.neonatalcann.ca/Parent%20Resources/Down%20Syndrome%20-%20Trisomy%2021.pdf